Literature DB >> 19439480

Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide.

Ikenna G Madu1, Shoshannah L Roth, Sandrine Belouzard, Gary R Whittaker.   

Abstract

Many viral fusion proteins are primed by proteolytic cleavage near their fusion peptides. While the coronavirus (CoV) spike (S) protein is known to be cleaved at the S1/S2 boundary, this cleavage site is not closely linked to a fusion peptide. However, a second cleavage site has been identified in the severe acute respiratory syndrome CoV (SARS-CoV) S2 domain (R797). Here, we investigated whether this internal cleavage of S2 exposes a viral fusion peptide. We show that the residues immediately C-terminal to the SARS-CoV S2 cleavage site SFIEDLLFNKVTLADAGF are very highly conserved across all CoVs. Mutagenesis studies of these residues in SARS-CoV S, followed by cell-cell fusion and pseudotyped virion infectivity assays, showed a critical role for residues L803, L804, and F805 in membrane fusion. Mutation of the most N-terminal residue (S798) had little or no effect on membrane fusion. Biochemical analyses of synthetic peptides corresponding to the proposed S2 fusion peptide also showed an important role for this region in membrane fusion and indicated the presence of alpha-helical structure. We propose that proteolytic cleavage within S2 exposes a novel internal fusion peptide for SARS-CoV S, which may be conserved across the Coronaviridae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439480      PMCID: PMC2708636          DOI: 10.1128/JVI.00079-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin.

Authors:  X Han; J H Bushweller; D S Cafiso; L K Tamm
Journal:  Nat Struct Biol       Date:  2001-08

Review 2.  Viral fusion peptides: a tool set to disrupt and connect biological membranes.

Authors:  L K Tamm; X Han
Journal:  Biosci Rep       Date:  2000-12       Impact factor: 3.840

3.  Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity.

Authors:  Fumihiro Taguchi; Yohko K Shimazaki
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

4.  Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.

Authors:  Hong Zhang; Guangwen Wang; Jian Li; Yuchun Nie; Xuanling Shi; Gewei Lian; Wei Wang; Xiaolei Yin; Yang Zhao; Xiuxia Qu; Mingxiao Ding; Hongkui Deng
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.

Authors:  Berend Jan Bosch; Ruurd van der Zee; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein.

Authors:  María J Gómara; Puig Mora; Ismael Mingarro; José L Nieva
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

7.  Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.

Authors:  Sandrine Belouzard; Victor C Chu; Gary R Whittaker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

8.  Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Authors:  Birke Bartosch; Jean Dubuisson; François-Loïc Cosset
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

Review 9.  Common properties of fusion peptides from diverse systems.

Authors:  I Martin; J M Ruysschaert
Journal:  Biosci Rep       Date:  2000-12       Impact factor: 3.840

10.  The SARS-CoV S glycoprotein: expression and functional characterization.

Authors:  Xiaodong Xiao; Samitabh Chakraborti; Anthony S Dimitrov; Kosi Gramatikoff; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

View more
  114 in total

1.  A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.

Authors:  Anthony C Wong; Rohini G Sandesara; Nirupama Mulherkar; Sean P Whelan; Kartik Chandran
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

2.  The presence of a single N-terminal histidine residue enhances the fusogenic properties of a Membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H.

Authors:  Stefania Galdiero; Annarita Falanga; Mariateresa Vitiello; Luca Raiola; Luigi Russo; Carlo Pedone; Carla Isernia; Massimiliano Galdiero
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

3.  Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting.

Authors:  Jean K Millet; Tiffany Tang; Lakshmi Nathan; Javier A Jaimes; Hung-Lun Hsu; Susan Daniel; Gary R Whittaker
Journal:  J Vis Exp       Date:  2019-03-01       Impact factor: 1.355

4.  Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.

Authors:  Kazuya Shirato; Kazuhiko Kanou; Miyuki Kawase; Shutoku Matsuyama
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

5.  A Single Point Mutation Creating a Furin Cleavage Site in the Spike Protein Renders Porcine Epidemic Diarrhea Coronavirus Trypsin Independent for Cell Entry and Fusion.

Authors:  Wentao Li; Oliver Wicht; Frank J M van Kuppeveld; Qigai He; Peter J M Rottier; Berend-Jan Bosch
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

6.  Ca2+ Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity.

Authors:  Marco R Straus; Tiffany Tang; Alex L Lai; Annkatrin Flegel; Miya Bidon; Jack H Freed; Susan Daniel; Gary R Whittaker
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

7.  Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell.

Authors:  Oliver Wicht; Christine Burkard; Cornelis A M de Haan; Frank J M van Kuppeveld; Peter J M Rottier; Berend Jan Bosch
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture.

Authors:  Oliver Wicht; Wentao Li; Lione Willems; Tom J Meuleman; Richard W Wubbolts; Frank J M van Kuppeveld; Peter J M Rottier; Berend Jan Bosch
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

9.  Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain.

Authors:  Sandrine Belouzard; Ikenna Madu; Gary R Whittaker
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

10.  Role of spike protein endodomains in regulating coronavirus entry.

Authors:  Ana Shulla; Tom Gallagher
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.